Equine Metabolic Syndrome Affects Viability, Senescence, and Stress Factors of Equine Adipose-Derived Mesenchymal Stromal Stem Cells: New Insight into EqASCs Isolated from EMS Horses in the Context of Their Aging

Table 1

Criteria for dividing the horses into the experimental and control group.

Group	O (number)	Sex	Main clinical parameters
			Bw	BCS	CNS	Fasting insulin	LEP	CGIT : GLU in 45 min
			(Kg)	(1–9)	(1–5)	(mU/mL)	(ng/mL)	(mg/dL)
Healthy horse	1	f	610	6	1	7	3,21	74/p
	2	f	644	7	2	12	4,12	69/p
	3	f	627	7	2	9	2,87	71/p
	4	m	609	6	1	8	1,86	89/p
	5	m	649	7	2	14	3,56	80/p
	6	m	639	6	2	13	2,91	74/p
Mean ± SD			629,7 ± 15,7	6,5 ± 0,5	1,7 ± 0,5	10,5 ± 2,6	3,1 ± 0,7	76,2 ± 6,7
Horse with EMS	1	f	710	8	3	83	4,89	138/p
	2	f	726	9	3	67	5,19	141/p
	3	f	760	9	4	98	9,12	140/p
	4	m	709	8	3	73	8,49	136/p
	5	m	716	8	4	69	7,27	134/p
	6	m	746	9	4	82	8,36	146/p
Mean ± SD			727,8 ± 19,1	8,5 ± 0,5	3,5 ± 0,5	78,7 ± 10,5	7,2 ± 1,6	139,2 ± 3,8

f: female, m: male, BW: body weight, BCS: body condition score, CNS: cresty neck score, CGIT: combined glucose-insulin test, SD: standard deviation, LEP: leptin, GLU: glucose, p: positive test results, and n: negative test results.